id	sid	eid	entity	type
ijpds-3318	1	1	kareenmulla et al	PERSON
ijpds-3318	1	2	1	CARDINAL
ijpds-3318	2	1	2	CARDINAL
ijpds-3318	3	1	2022	CARDINAL
ijpds-3318	3	2	indian	NORP
ijpds-3318	3	3	j pharm drug	PRODUCT
ijpds-3318	3	4	63	CARDINAL
ijpds-3318	3	5	2	CARDINAL
ijpds-3318	3	6	bingi1	PERSON
ijpds-3318	3	7	shaik kareemulla2	PERSON
ijpds-3318	3	8	b. himabindu3	PERSON
ijpds-3318	3	9	d. sheklane khan3	PERSON
ijpds-3318	3	10	s. mahammed rafi3	PERSON
ijpds-3318	3	11	1assistant	CARDINAL
ijpds-3318	3	12	ggh	PERSON
ijpds-3318	3	13	2associate	CARDINAL
ijpds-3318	3	14	3pharmd	CARDINAL
ijpds-3318	3	15	rami reddy pharmacy college	PERSON
ijpds-3318	3	16	kadapa andhra pradesh.	ORG
ijpds-3318	4	1	shaik kareemulla	PERSON
ijpds-3318	5	1	rami reddy memorial college	PERSON
ijpds-3318	5	2	kadapa	NORP
ijpds-3318	5	3	andhra pradesh	ORG
ijpds-3318	8	1	2	CARDINAL
ijpds-3318	9	1	2	CARDINAL
ijpds-3318	11	1	6 months	DATE
ijpds-3318	11	2	india	GPE
ijpds-3318	12	1	100	CARDINAL
ijpds-3318	12	2	2	CARDINAL
ijpds-3318	12	3	50	CARDINAL
ijpds-3318	13	1	1	CARDINAL
ijpds-3318	13	2	2	CARDINAL
ijpds-3318	15	1	0.50%	PERCENT
ijpds-3318	15	2	85mg	DATE
ijpds-3318	15	3	1	CARDINAL
ijpds-3318	15	4	0.35%	PERCENT
ijpds-3318	15	5	15mg	DATE
ijpds-3318	15	6	2	CARDINAL
ijpds-3318	15	7	gm	ORG
ijpds-3318	16	1	24	CARDINAL
ijpds-3318	16	2	1	CARDINAL
ijpds-3318	16	3	46	CARDINAL
ijpds-3318	16	4	2	CARDINAL
ijpds-3318	18	1	ris ks	PERSON
ijpds-3318	19	1	2	CARDINAL
ijpds-3318	19	2	adr	ORG
ijpds-3318	19	3	idf	ORG
ijpds-3318	19	4	2013	DATE
ijpds-3318	19	5	20-79 years old	DATE
ijpds-3318	19	6	8.3%	PERCENT
ijpds-3318	19	7	382 million	CARDINAL
ijpds-3318	19	8	14 million	CARDINAL
ijpds-3318	19	9	198 million	CARDINAL
ijpds-3318	19	10	184 million	CARDINAL
ijpds-3318	20	1	between 40 to 59 years	CARDINAL
ijpds-3318	20	2	592 million	CARDINAL
ijpds-3318	20	3	2035	CARDINAL
ijpds-3318	20	4	10.1%	PERCENT
ijpds-3318	21	1	1	CARDINAL
ijpds-3318	22	1	ada	PERSON
ijpds-3318	22	2	1989	DATE
ijpds-3318	24	1	ada	ORG
ijpds-3318	25	1	first	ORDINAL
ijpds-3318	25	2	4	CARDINAL
ijpds-3318	25	3	2	CARDINAL
ijpds-3318	25	4	2	CARDINAL
ijpds-3318	26	1	japanese	NORP
ijpds-3318	27	1	3	CARDINAL
ijpds-3318	28	1	sanjay et al	PERSON
ijpds-3318	28	2	indian	NORP
ijpds-3318	28	3	4	CARDINAL
ijpds-3318	29	1	zang et al	PERSON
ijpds-3318	29	2	chinese	NORP
ijpds-3318	30	1	5	CARDINAL
ijpds-3318	30	2	6	CARDINAL
ijpds-3318	31	1	yavropoulou et al	PERSON
ijpds-3318	32	1	2	CARDINAL
ijpds-3318	33	1	1	CARDINAL
ijpds-3318	33	2	2	CARDINAL
ijpds-3318	34	1	2022	CARDINAL
ijpds-3318	34	2	indian	NORP
ijpds-3318	34	3	j pharm drug	PRODUCT
ijpds-3318	34	4	64	CARDINAL
ijpds-3318	34	5	india	GPE
ijpds-3318	34	6	6 years	DATE
ijpds-3318	34	7	december 2020	DATE
ijpds-3318	34	8	2021	CARDINAL
ijpds-3318	35	1	the institutional ethical committee	ORG
ijpds-3318	36	1	2070 years	DATE
ijpds-3318	36	2	2	CARDINAL
ijpds-3318	36	3	2	CARDINAL
ijpds-3318	37	1	70 years	DATE
ijpds-3318	37	2	1	CARDINAL
ijpds-3318	38	1	100	CARDINAL
ijpds-3318	38	2	2	CARDINAL
ijpds-3318	39	1	12 weeks	DATE
ijpds-3318	39	2	every 4 weeks	DATE
ijpds-3318	40	1	two	CARDINAL
ijpds-3318	40	2	2	CARDINAL
ijpds-3318	41	1	2	CARDINAL
ijpds-3318	42	1	4 weeks	DATE
ijpds-3318	43	1	group	ORG
ijpds-3318	43	2	6 months	DATE
ijpds-3318	44	1	the end of 6 months	DATE
ijpds-3318	48	1	anova	ORG
ijpds-3318	48	2	spss	ORG
ijpds-3318	48	3	21.0	CARDINAL
ijpds-3318	49	1	the institutional ethical committee of rims hospital	ORG
ijpds-3318	51	1	100	CARDINAL
ijpds-3318	52	1	65(65%	PERCENT
ijpds-3318	53	1	50	CARDINAL
ijpds-3318	53	2	50	CARDINAL
ijpds-3318	54	1	35	CARDINAL
ijpds-3318	54	2	70%	PERCENT
ijpds-3318	54	3	15(30%	PERCENT
ijpds-3318	55	1	30(60%	PERCENT
ijpds-3318	55	2	20(40%	PERCENT
ijpds-3318	56	1	1	CARDINAL
ijpds-3318	56	2	1	CARDINAL
ijpds-3318	56	3	50	CARDINAL
ijpds-3318	56	4	22	DATE
ijpds-3318	56	5	44%	PERCENT
ijpds-3318	56	6	50-59 years age	DATE
ijpds-3318	56	7	2(4%	PERCENT
ijpds-3318	56	8	20-29 years age	DATE
ijpds-3318	56	9	6(12%	PERCENT
ijpds-3318	56	10	30-39 years age	DATE
ijpds-3318	56	11	9(18%	PERCENT
ijpds-3318	56	12	40-49 years age	DATE
ijpds-3318	56	13	11(22%	PERCENT
ijpds-3318	56	14	60-69 years age	DATE
ijpds-3318	57	1	50	CARDINAL
ijpds-3318	57	2	20(40%	PERCENT
ijpds-3318	57	3	40-49 years age	DATE
ijpds-3318	57	4	4(8%	PERCENT
ijpds-3318	57	5	20-29 years age	DATE
ijpds-3318	57	6	2(4%	PERCENT
ijpds-3318	57	7	30-39 years age	DATE
ijpds-3318	57	8	16(32%	PERCENT
ijpds-3318	57	9	50-59 years age	DATE
ijpds-3318	57	10	8(16%	PERCENT
ijpds-3318	57	11	60-69 years age	DATE
ijpds-3318	58	1	100	CARDINAL
ijpds-3318	58	2	38	CARDINAL
ijpds-3318	58	3	50-59 years	DATE
ijpds-3318	58	4	6	CARDINAL
ijpds-3318	58	5	20-29 years age	DATE
ijpds-3318	58	6	8	CARDINAL
ijpds-3318	58	7	30-39 years age	DATE
ijpds-3318	58	8	29	CARDINAL
ijpds-3318	58	9	40-49 years age	DATE
ijpds-3318	58	10	19	CARDINAL
ijpds-3318	58	11	60-69 years age	DATE
ijpds-3318	59	1	2	CARDINAL
ijpds-3318	59	2	2	CARDINAL
ijpds-3318	59	3	35	CARDINAL
ijpds-3318	59	4	15	CARDINAL
ijpds-3318	59	5	30	CARDINAL
ijpds-3318	59	6	20	CARDINAL
ijpds-3318	59	7	2 6 9	TIME
ijpds-3318	59	8	11	CARDINAL
ijpds-3318	59	9	1	CARDINAL
ijpds-3318	60	1	2	CARDINAL
ijpds-3318	61	1	2022	CARDINAL
ijpds-3318	61	2	indian	NORP
ijpds-3318	61	3	j pharm drug	PRODUCT
ijpds-3318	61	4	65	CARDINAL
ijpds-3318	61	5	50	CARDINAL
ijpds-3318	61	6	33	CARDINAL
ijpds-3318	62	1	13(40%	PERCENT
ijpds-3318	62	2	4(12%	PERCENT
ijpds-3318	62	3	3(9%	PERCENT
ijpds-3318	62	4	9(27%	PERCENT
ijpds-3318	62	5	2(6%	PERCENT
ijpds-3318	63	1	50	CARDINAL
ijpds-3318	63	2	gm	ORG
ijpds-3318	63	3	35	CARDINAL
ijpds-3318	64	1	14(40%	PERCENT
ijpds-3318	64	2	5(14%	PERCENT
ijpds-3318	64	3	10(28%	PERCENT
ijpds-3318	64	4	2(6%	PERCENT
ijpds-3318	65	1	100	CARDINAL
ijpds-3318	65	2	68	CARDINAL
ijpds-3318	66	1	27(40%	PERCENT
ijpds-3318	66	2	6(9%	PERCENT
ijpds-3318	66	3	8(12%	PERCENT
ijpds-3318	66	4	4(6%	PERCENT
ijpds-3318	67	1	3	CARDINAL
ijpds-3318	67	2	3	CARDINAL
ijpds-3318	67	3	gm	ORG
ijpds-3318	68	1	gm	ORG
ijpds-3318	69	1	2	CARDINAL
ijpds-3318	70	1	first	ORDINAL
ijpds-3318	73	1	8	CARDINAL
ijpds-3318	75	1	first	ORDINAL
ijpds-3318	77	1	2	CARDINAL
ijpds-3318	78	1	9	CARDINAL
ijpds-3318	81	1	dpp-4	ORG
ijpds-3318	82	1	vildagliptin	ORG
ijpds-3318	86	1	10	CARDINAL
ijpds-3318	90	1	the initial three months	DATE
ijpds-3318	90	2	11	CARDINAL
ijpds-3318	91	1	biswanath et al	PERSON
ijpds-3318	91	2	12	CARDINAL
ijpds-3318	91	3	13	CARDINAL
ijpds-3318	92	1	li-nong ji et al	PERSON
ijpds-3318	93	1	14	CARDINAL
ijpds-3318	94	1	hye-soon	PERSON
ijpds-3318	94	2	kim et al.	PERSON
ijpds-3318	94	3	2	CARDINAL
ijpds-3318	94	4	lowdose metformin	PERSON
ijpds-3318	95	1	15	CARDINAL
ijpds-3318	96	1	manuel gonzalez et al	PERSON
ijpds-3318	96	2	2	CARDINAL
ijpds-3318	97	1	16	CARDINAL
ijpds-3318	98	1	7.25%	PERCENT
ijpds-3318	98	2	6.75%	PERCENT
ijpds-3318	99	1	7.50%	PERCENT
ijpds-3318	99	2	7.15%	PERCENT
ijpds-3318	100	1	1	CARDINAL
ijpds-3318	100	2	2	CARDINAL
ijpds-3318	101	1	2022	CARDINAL
ijpds-3318	101	2	indian	NORP
ijpds-3318	101	3	j pharm drug	PRODUCT
ijpds-3318	101	4	66	CARDINAL
ijpds-3318	101	5	week 12	DATE
ijpds-3318	101	6	0.50%	PERCENT
ijpds-3318	101	7	0.35%	PERCENT
ijpds-3318	102	1	gm	ORG
ijpds-3318	102	2	1	CARDINAL
ijpds-3318	102	3	1	CARDINAL
ijpds-3318	102	4	gm	ORG
ijpds-3318	103	1	week 0	DATE
ijpds-3318	103	2	7.25%	PERCENT
ijpds-3318	103	3	6.75%	PERCENT
ijpds-3318	103	4	0.50%	PERCENT
ijpds-3318	103	5	7.50%	PERCENT
ijpds-3318	103	6	7.15%	PERCENT
ijpds-3318	103	7	0.35%	PERCENT
ijpds-3318	103	8	145 mg	QUANTITY
ijpds-3318	103	9	138mg	PERSON
ijpds-3318	103	10	133mg	ORG
ijpds-3318	103	11	125mg	ORG
ijpds-3318	103	12	1 st, 2nd	GPE
ijpds-3318	103	13	3rd	ORDINAL
ijpds-3318	104	1	137mg	ORG
ijpds-3318	104	2	135mg	PRODUCT
ijpds-3318	104	3	130mg	ORG
ijpds-3318	104	4	1 st, 2nd	GPE
ijpds-3318	104	5	3	CARDINAL
ijpds-3318	105	1	12mg	ORG
ijpds-3318	106	1	2	CARDINAL
ijpds-3318	106	2	2	CARDINAL
ijpds-3318	106	3	1st	ORDINAL
ijpds-3318	106	4	2nd	ORDINAL
ijpds-3318	106	5	3rd	ORDINAL
ijpds-3318	106	6	3rd	ORDINAL
ijpds-3318	106	7	145	CARDINAL
ijpds-3318	106	8	133	CARDINAL
ijpds-3318	106	9	20	CARDINAL
ijpds-3318	106	10	142	CARDINAL
ijpds-3318	106	11	137	CARDINAL
ijpds-3318	106	12	135	CARDINAL
ijpds-3318	106	13	130 12	CARDINAL
ijpds-3318	106	14	270 mg	QUANTITY
ijpds-3318	106	15	245mg	ORG
ijpds-3318	106	16	210mg	ORG
ijpds-3318	106	17	1st	DATE
ijpds-3318	106	18	2nd	ORDINAL
ijpds-3318	106	19	3rd	ORDINAL
ijpds-3318	107	1	235mg	WORK_OF_ART
ijpds-3318	107	2	205mg	ORG
ijpds-3318	107	3	195mg	ORG
ijpds-3318	107	4	1st	DATE
ijpds-3318	107	5	2nd	ORDINAL
ijpds-3318	107	6	3rd	ORDINAL
ijpds-3318	108	1	85mg	DATE
ijpds-3318	109	1	gm	ORG
ijpds-3318	110	1	3	CARDINAL
ijpds-3318	112	1	50	CARDINAL
ijpds-3318	112	2	24	CARDINAL
ijpds-3318	112	3	18	CARDINAL
ijpds-3318	113	1	8	DATE
ijpds-3318	113	2	6	CARDINAL
ijpds-3318	113	3	4	CARDINAL
ijpds-3318	113	4	2	CARDINAL
ijpds-3318	113	5	3	CARDINAL
ijpds-3318	113	6	1st	ORDINAL
ijpds-3318	113	7	2nd	ORDINAL
ijpds-3318	113	8	3rd	ORDINAL
ijpds-3318	113	9	3rd	ORDINAL
ijpds-3318	113	10	270	CARDINAL
ijpds-3318	113	11	245	CARDINAL
ijpds-3318	113	12	210	CARDINAL
ijpds-3318	113	13	185	CARDINAL
ijpds-3318	113	14	85	CARDINAL
ijpds-3318	113	15	250	CARDINAL
ijpds-3318	113	16	235	CARDINAL
ijpds-3318	113	17	205	CARDINAL
ijpds-3318	113	18	195	CARDINAL
ijpds-3318	113	19	55	CARDINAL
ijpds-3318	113	20	50	CARDINAL
ijpds-3318	113	21	46	CARDINAL
ijpds-3318	113	22	32	CARDINAL
ijpds-3318	114	1	12	DATE
ijpds-3318	114	2	6	CARDINAL
ijpds-3318	114	3	10	CARDINAL
ijpds-3318	114	4	8	DATE
ijpds-3318	114	5	4	CARDINAL
ijpds-3318	114	6	4	CARDINAL
ijpds-3318	114	7	n=24	ORG
ijpds-3318	114	8	2 8 10	DATE
ijpds-3318	114	9	4	CARDINAL
ijpds-3318	114	10	14	CARDINAL
ijpds-3318	114	11	6 6 12	CARDINAL
ijpds-3318	114	12	8 12 20	DATE
ijpds-3318	114	13	100	CARDINAL
ijpds-3318	114	14	70	CARDINAL
ijpds-3318	114	15	50	CARDINAL
ijpds-3318	115	1	20	DATE
ijpds-3318	115	2	12	CARDINAL
ijpds-3318	115	3	14	CARDINAL
ijpds-3318	116	1	24	CARDINAL
ijpds-3318	116	2	46	CARDINAL
ijpds-3318	117	1	5	CARDINAL
ijpds-3318	118	1	the end of 12 weeks	DATE
ijpds-3318	119	1	5	CARDINAL
ijpds-3318	119	2	24 36%	PERCENT
ijpds-3318	119	3	46 65%	PERCENT
ijpds-3318	119	4	gm	ORG
ijpds-3318	120	1	1	CARDINAL
ijpds-3318	121	1	2	CARDINAL
ijpds-3318	122	1	2022	CARDINAL
ijpds-3318	122	2	indian	NORP
ijpds-3318	122	3	j pharm drug	PRODUCT
ijpds-3318	122	4	67	CARDINAL
ijpds-3318	123	1	years	DATE
ijpds-3318	123	2	the american diabetes association	ORG
ijpds-3318	124	1	below 7 percent	PERCENT
ijpds-3318	125	1	the american association of clinical	ORG
ijpds-3318	125	2	6.5 percent	PERCENT
ijpds-3318	126	1	2	CARDINAL
ijpds-3318	129	1	oriental	NORP
ijpds-3318	133	1	weightgain	PERSON
ijpds-3318	135	1	2	CARDINAL
ijpds-3318	135	2	8	CARDINAL
ijpds-3318	135	3	gm	ORG
ijpds-3318	139	1	ada	PERSON
ijpds-3318	139	2	american	NORP
ijpds-3318	139	3	adr	ORG
ijpds-3318	139	4	anova	ORG
ijpds-3318	139	5	cdc	ORG
ijpds-3318	139	6	chd	ORG
ijpds-3318	139	7	ci	PERSON
ijpds-3318	139	8	dme	ORG
ijpds-3318	139	9	dpp4	PERSON
ijpds-3318	139	10	di peptidyl peptidase	PERSON
ijpds-3318	139	11	fda	ORG
ijpds-3318	139	12	food and drug administration	ORG
ijpds-3318	139	13	fpg	ORG
ijpds-3318	139	14	gcp	ORG
ijpds-3318	139	15	gfr	ORG
ijpds-3318	139	16	ggh	PERSON
ijpds-3318	139	17	gm	ORG
ijpds-3318	139	18	icd	ORG
ijpds-3318	139	19	ich: international council of harmonisation	ORG
ijpds-3318	139	20	idf	ORG
ijpds-3318	139	21	iec: institutional ethical committee	ORG
ijpds-3318	139	22	igt	ORG
ijpds-3318	140	1	1	CARDINAL
ijpds-3318	140	2	david whiting	PERSON
ijpds-3318	142	1	sixth	ORDINAL
ijpds-3318	142	2	2013	DATE
ijpds-3318	143	1	idf	ORG
ijpds-3318	143	2	atlas	PERSON
ijpds-3318	144	1	2.	CARDINAL
ijpds-3318	144	2	chiang jl	PERSON
ijpds-3318	144	3	kirkman ms	PERSON
ijpds-3318	144	4	laffel lmb et al	PERSON
ijpds-3318	144	5	1	CARDINAL
ijpds-3318	144	6	the american diabetes association	ORG
ijpds-3318	146	1	2014	DATE
ijpds-3318	146	2	37	CARDINAL
ijpds-3318	146	3	2034 54	DATE
ijpds-3318	147	1	3	CARDINAL
ijpds-3318	147	2	hayashi t	PERSON
ijpds-3318	147	3	murayama	GPE
ijpds-3318	147	4	52-week	DATE
ijpds-3318	147	5	japanese	NORP
ijpds-3318	147	6	2	CARDINAL
ijpds-3318	149	1	2020	DATE
ijpds-3318	149	2	21	CARDINAL
ijpds-3318	149	3	121 30	DATE
ijpds-3318	150	1	4	CARDINAL
ijpds-3318	150	2	bajaj s	ORG
ijpds-3318	150	3	unnikrishnan ag	ORG
ijpds-3318	151	1	first	ORDINAL
ijpds-3318	151	2	indian	NORP
ijpds-3318	151	3	2	CARDINAL
ijpds-3318	152	1	indian	NORP
ijpds-3318	153	1	2019	DATE
ijpds-3318	153	2	23	CARDINAL
ijpds-3318	153	3	312 7	CARDINAL
ijpds-3318	153	4	5	CARDINAL
ijpds-3318	153	5	zang l	PERSON
ijpds-3318	153	6	han	NORP
ijpds-3318	153	7	chen l	PERSON
ijpds-3318	153	8	2	CARDINAL
ijpds-3318	153	9	china	GPE
ijpds-3318	155	1	2019	DATE
ijpds-3318	155	2	10	CARDINAL
ijpds-3318	155	3	1391 405	DATE
ijpds-3318	156	1	6	CARDINAL
ijpds-3318	156	2	gullapalli h	PERSON
ijpds-3318	156	3	desai s.	PERSON
ijpds-3318	156	4	2	CARDINAL
ijpds-3318	157	1	natl	ORG
ijpds-3318	157	2	j physiol pharm pharmacol	PERSON
ijpds-3318	158	1	2018	DATE
ijpds-3318	158	2	8	CARDINAL
ijpds-3318	158	3	521 5	CARDINAL
ijpds-3318	158	4	7	CARDINAL
ijpds-3318	158	5	yavropoulou mp	PERSON
ijpds-3318	158	6	pikilidou m	PERSON
ijpds-3318	159	1	first	ORDINAL
ijpds-3318	159	2	2	CARDINAL
ijpds-3318	160	1	metab disord	ORG
ijpds-3318	161	1	2015	CARDINAL
ijpds-3318	161	2	14	CARDINAL
ijpds-3318	161	3	118	CARDINAL
ijpds-3318	161	4	8	CARDINAL
ijpds-3318	162	1	nathan dm	PERSON
ijpds-3318	164	1	2	CARDINAL
ijpds-3318	165	1	2002	DATE
ijpds-3318	165	2	347	CARDINAL
ijpds-3318	165	3	1342 9. 9	DATE
ijpds-3318	166	1	mc	PERSON
ijpds-3318	168	1	42	CARDINAL
ijpds-3318	168	2	2161 3. 10	DATE
ijpds-3318	169	1	degrande e. vildagliptin:	PERSON
ijpds-3318	169	2	2	CARDINAL
ijpds-3318	170	1	2008	DATE
ijpds-3318	170	2	4	CARDINAL
ijpds-3318	170	3	1349 60	DATE
ijpds-3318	171	1	11	CARDINAL
ijpds-3318	172	1	hayashi t	PERSON
ijpds-3318	172	2	murayama	GPE
ijpds-3318	172	3	52-week	DATE
ijpds-3318	172	4	japanese	NORP
ijpds-3318	172	5	2	CARDINAL
ijpds-3318	172	6	antidiabetics	PERSON
ijpds-3318	173	1	opin pharmac other	PERSON
ijpds-3318	174	1	2020	DATE
ijpds-3318	174	2	21	CARDINAL
ijpds-3318	174	3	121 30.	DATE
ijpds-3318	175	1	12	CARDINAL
ijpds-3318	176	1	sarkar bs	PERSON
ijpds-3318	176	2	mukherjee s	PERSON
ijpds-3318	177	1	2	CARDINAL
ijpds-3318	178	1	j clin diagn res	PERSON
ijpds-3318	178	2	2019	DATE
ijpds-3318	178	3	13	CARDINAL
ijpds-3318	178	4	oc09 oc11	PRODUCT
ijpds-3318	179	1	13	CARDINAL
ijpds-3318	180	1	cohen cm	PERSON
ijpds-3318	180	2	davis	PERSON
ijpds-3318	180	3	2	CARDINAL
ijpds-3318	182	1	2018	DATE
ijpds-3318	182	2	10	CARDINAL
ijpds-3318	182	3	68 72	DATE
ijpds-3318	183	1	14	DATE
ijpds-3318	184	1	li-nong ji	PERSON
ijpds-3318	184	2	chang-yu pan	PERSON
ijpds-3318	184	3	ju-ming lu	PERSON
ijpds-3318	184	4	chinese	NORP
ijpds-3318	184	5	2	CARDINAL
ijpds-3318	186	1	2013	DATE
ijpds-3318	186	2	12	CARDINAL
ijpds-3318	186	3	118	CARDINAL
ijpds-3318	187	1	kareenmulla et al	PERSON
ijpds-3318	187	2	1	CARDINAL
ijpds-3318	188	1	2	CARDINAL
ijpds-3318	189	1	2022	CARDINAL
ijpds-3318	189	2	indian	NORP
ijpds-3318	189	3	j pharm drug	PRODUCT
ijpds-3318	189	4	68 15	DATE
ijpds-3318	190	1	hye-soon	PERSON
ijpds-3318	190	2	kim	PERSON
ijpds-3318	190	3	kim	PERSON
ijpds-3318	190	4	2	CARDINAL
ijpds-3318	190	5	korea	GPE
ijpds-3318	191	1	j. diabetes	PERSON
ijpds-3318	192	1	2014	DATE
ijpds-3318	192	2	5(6	CARDINAL
ijpds-3318	192	3	701 708	CARDINAL
ijpds-3318	193	1	16	CARDINAL
ijpds-3318	194	1	manuel gonzale	PERSON
ijpds-3318	194	2	guerrero romero	PERSON
ijpds-3318	194	3	rafael violanteortiz	PERSON
ijpds-3318	194	4	2	CARDINAL
ijpds-3318	196	1	2009	DATE
ijpds-3318	196	2	23(6	CARDINAL
ijpds-3318	196	3	376379	DATE
ijpds-3318	197	1	bingi p	PERSON
ijpds-3318	197	2	kareemulla s	ORG
ijpds-3318	197	3	khan ds	PERSON
ijpds-3318	197	4	rafi s.	PERSON
ijpds-3318	197	5	2	CARDINAL
ijpds-3318	198	1	indian	NORP
ijpds-3318	199	1	2022	CARDINAL
ijpds-3318	199	2	1(2	CARDINAL
ijpds-3318	199	3	63	CARDINAL